ANI Pharmaceuticals | ANIP - 負債





負債 変化する 日付
AbbVie USD 72.86B 5.36B 2026-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Heron Therapeutics USD 149.65M 157K 2024-09
Hikma Pharmaceutical USD 1.6B 46M 2025-12
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 47B 14.98B 2026-03
Omeros USD 442.16M 199K 2023-09
Perrigo USD 3.63B 7.7M 2026-03
Sun Pharmaceuticals INR 46.27B 22.65B 2026-03
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03